當前位置：賽默飛世爾科技（中國）有限公司>>Western 免疫印跡產品>>抗體結合蛋白和偶聯物>>CaptureSelect™ Biotin Anti-LC-kappa (Human) Conjugate

CaptureSelect™ Biotin Anti-LC-kappa (Human) Conjugate

返回列表頁

參考價

面議

具體成交價以合同協議為準

產品型號Thermo Scientific

品牌

廠商性質其他

所在地

在線詢價收藏產品查看聯系電話

聯系方式：查看聯系方式

更新時間：2023-11-06 15:53:04瀏覽次數：220次

聯系我時，請告知來自環保在線

產品分類 品牌分類

  Western 免疫印跡產品

Western 印跡設備和耗材

Western 印跡和核酸膜及濾紙

通用 Western 印跡試劑

抗體結合蛋白和偶聯物

Western 印跡底物和底物試劑盒

蛋白方法封閉緩沖液

靶標特異性 Western 印跡試劑盒

X 射線膜和耗材

結合蛋白和偶聯物

全部產品列表

暫無信息

賽默飛世爾科技（中國）有限公司

經營模式：其他

商鋪產品：2514條

所在地區：

詢價 給他留言

產品簡介

CaptureSelect™ Biotin Anti-LC-kappa (Human) Conjugate

詳細介紹

CaptureSelect™ Biotin Anti-LC-kappa (Hu) Conjugate consists of a 13 kDa recombinant single domain antibody fragment (VHH affinity ligand) that specifically binds to the constant domain of human kappa light chains. The affinity ligａnd is chemically conjugated to biotin via an appropriate spacer that retains the binding reactivity of the ligａnd when used in combination with streptavidin-based conjugates or streptavidin pre-coated surfaces.

The CaptureSelect™ Biotin Anti-LC-kappa (Hu) Conjugate allows you to:

• Detect, quantitate, and characterize all human antibody isotypes and subclasses (for example, IgG1 to 4, IgM, IgA, IgD, and IgE), and Fab fragments thereof, that contain a kappa light chain; as well as recombinant human Fab fragments and/or Fab and Fab2 fragments obtained after papain or pepsin digestion
• Avoid cross-binding with human antibodies that possess a lambda light chain or IgG from bovine sources such as FCS
• Screen antibody-antigen interactions—biotin anti-LC-kappa (Hu) forms a stable [low k(diss)] complex with, for example, human IgG antibodies through bivalent binding

Applications for CaptureSelect™ Biotin Anti-LC-kappa (Hu) Conjugate include ELISA, Western blot, Gyrolab™-based immunoassays, and label-free detection platforms such as those based on surface plasmon resonance (Biacore™ and IBIS-MX96 systems) and bio-layer interferometry (ForteBio™ Octet™ systems).

Free of animal components
CaptureSelect products contain affinity ligands based on recombinant single-domain antibody fragments (VHH) created by a proprietary technology. The VHH affinity ligａnd is a 12 to 15 kDa fragment comprising the three complementarity-determining regions (CDRs) that form the antigen-binding domain, efficiently produced in the yeast Saccharomyces cerevisiae by a production process free of any animal components (Animal Origin-Free).

For Research Use Only. Not for use in diagnostic procedures.